These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 2243441)
21. Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients. Clark GM; Mathieu MC; Owens MA; Dressler LG; Eudey L; Tormey DC; Osborne CK; Gilchrist KW; Mansour EG; Abeloff MD J Clin Oncol; 1992 Mar; 10(3):428-32. PubMed ID: 1740681 [TBL] [Abstract][Full Text] [Related]
22. Breast carcinoma growth rate described by mammographic doubling time and S-phase fraction. Correlations to clinical and histopathologic factors in a screened population. Arnerlöv C; Emdin SO; Lundgren B; Roos G; Söderström J; Bjersing L; Norberg C; Angquist KA Cancer; 1992 Oct; 70(7):1928-34. PubMed ID: 1525768 [TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast. Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277 [TBL] [Abstract][Full Text] [Related]
24. The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting. Wong SW; Rangan AM; Bilous AM; Boyages J; Gebski V; Benson EM Pathology; 1999 May; 31(2):90-4. PubMed ID: 10399161 [TBL] [Abstract][Full Text] [Related]
25. Sex steroid receptors, S-phase fraction and DNA ploidy as determinants of the risk of relapse and death of female breast cancer. Lipponen P; Eskelinen M; Papinaho S; Klemi PJ; Aaltomaa S; Kosma VM; Marin S; Syrjänen K Anticancer Res; 1992; 12(3):677-82. PubMed ID: 1622125 [TBL] [Abstract][Full Text] [Related]
26. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient. Haffty BG; Toth M; Flynn S; Fischer D; Carter D J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198 [TBL] [Abstract][Full Text] [Related]
27. The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre. Camplejohn RS; Ash CM; Gillett CE; Raikundalia B; Barnes DM; Gregory WM; Richards MA; Millis RR Br J Cancer; 1995 Jan; 71(1):140-5. PubMed ID: 7819030 [TBL] [Abstract][Full Text] [Related]
28. Flow cytometric analysis of primary tumors and their corresponding metastatic nodes in breast cancer. Kang HS; Youn YK; Oh SK; Choe KJ; Noh DY Breast Cancer Res Treat; 2000 Sep; 63(1):81-7. PubMed ID: 11079162 [TBL] [Abstract][Full Text] [Related]
29. Markers of prognosis in breast cancer--the relationship between binding of the lectin HPA and histological grade, SPF, and ploidy. Brooks SA; Leathem AJ; Camplejohn RS; Gregory W Breast Cancer Res Treat; 1993; 25(3):247-56. PubMed ID: 8369526 [TBL] [Abstract][Full Text] [Related]
30. [Flow cytometry detected S-phase fraction and ploidy as prognostic parameters in primary, node-negative breast cancer]. Winter K; Eidtmann H; Jonat W Geburtshilfe Frauenheilkd; 1994 May; 54(5):291-4. PubMed ID: 8050690 [TBL] [Abstract][Full Text] [Related]
31. The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up. Toikkanen S; Joensuu H; Klemi P Br J Cancer; 1989 Nov; 60(5):693-700. PubMed ID: 2553094 [TBL] [Abstract][Full Text] [Related]
32. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters. Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041 [TBL] [Abstract][Full Text] [Related]
33. Flow cytometric DNA ploidy and S-phase heterogeneity in advanced ovarian carcinoma. Kaern J; Tropé CG; Kristensen GB; Pettersen EO Cancer; 1994 Apr; 73(7):1870-7. PubMed ID: 8137213 [TBL] [Abstract][Full Text] [Related]
34. Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer. Stanton PD; Cooke TG; Oakes SJ; Winstanley J; Holt S; George WD; Murray GD Br J Cancer; 1992 Nov; 66(5):925-9. PubMed ID: 1419638 [TBL] [Abstract][Full Text] [Related]
35. Patterns of DNA ploidy and S-phase fraction associated with breast cancer survival in blacks and whites. Shiao YH; Chen VW; Lehmann HP; Wu XC; Correa P Clin Cancer Res; 1997 Apr; 3(4):587-92. PubMed ID: 9815724 [TBL] [Abstract][Full Text] [Related]
36. Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates. Baldetorp B; Bendahl PO; Fernö M; Alanen K; Delle U; Falkmer U; Hansson-Aggesjö B; Höckenström T; Lindgren A; Mossberg L Cytometry; 1995 Jun; 22(2):115-27. PubMed ID: 7587742 [TBL] [Abstract][Full Text] [Related]
37. Relationship of DNA ploidy and S-phase fraction to survival after first recurrence of breast cancer. Stål O; Carstensen JM; Wingren S; Rutqvist LE; Skoog L; Klintenberg C; Nordenskjöld B Acta Oncol; 1994; 33(4):423-9. PubMed ID: 8018376 [TBL] [Abstract][Full Text] [Related]
38. Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome. Fernö M; Baldetorp B; Borg A; Olsson H; Sigurdsson H; Killander D Acta Oncol; 1992; 31(2):157-65. PubMed ID: 1622630 [TBL] [Abstract][Full Text] [Related]
39. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Dressler LG; Seamer LC; Owens MA; Clark GM; McGuire WL Cancer; 1988 Feb; 61(3):420-7. PubMed ID: 3338012 [TBL] [Abstract][Full Text] [Related]
40. [Expression of adhesive molecule CD44v6 and p53 gene in breast cancer tissues and its relation with DNA ploidy]. Zuo WS; Wei L; Wang XW; Wang YS; Yu ZY Ai Zheng; 2004 Nov; 23(11 Suppl):1418-22. PubMed ID: 15566648 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]